286 related articles for article (PubMed ID: 31244927)
1. Nanozyme-mediated catalytic nanotherapy for inflammatory bowel disease.
Zhao J; Gao W; Cai X; Xu J; Zou D; Li Z; Hu B; Zheng Y
Theranostics; 2019; 9(10):2843-2855. PubMed ID: 31244927
[TBL] [Abstract][Full Text] [Related]
2. Mn
Yang Z; Zhou X; Wang L; Guo H; Han M; Guo H; Chen Y; Wu A; Li H; Chen S; Xie Y; Wang X
ACS Appl Mater Interfaces; 2023 Jul; 15(28):33273-33287. PubMed ID: 37410395
[TBL] [Abstract][Full Text] [Related]
3. A superoxide dismutase/catalase mimetic nanomedicine for targeted therapy of inflammatory bowel disease.
Zhang Q; Tao H; Lin Y; Hu Y; An H; Zhang D; Feng S; Hu H; Wang R; Li X; Zhang J
Biomaterials; 2016 Oct; 105():206-221. PubMed ID: 27525680
[TBL] [Abstract][Full Text] [Related]
4. Prussian Blue Nanozyme with Multienzyme Activity Reduces Colitis in Mice.
Zhao J; Cai X; Gao W; Zhang L; Zou D; Zheng Y; Li Z; Chen H
ACS Appl Mater Interfaces; 2018 Aug; 10(31):26108-26117. PubMed ID: 30028115
[TBL] [Abstract][Full Text] [Related]
5. Manganese Prussian blue nanozymes with antioxidant capacity prevent acetaminophen-induced acute liver injury.
Chen C; Wu H; Li Q; Liu M; Yin F; Wu M; Wei X; Wang H; Zha Z; Wang F
Biomater Sci; 2023 Mar; 11(7):2348-2358. PubMed ID: 36722889
[TBL] [Abstract][Full Text] [Related]
6. Zero-Valence Selenium-Enriched Prussian Blue Nanozymes Reconstruct Intestinal Barrier against Inflammatory Bowel Disease via Inhibiting Ferroptosis and T Cells Differentiation.
Zhu D; Wu H; Jiang K; Xu Y; Miao Z; Wang H; Ma Y
Adv Healthc Mater; 2023 May; 12(12):e2203160. PubMed ID: 36651877
[TBL] [Abstract][Full Text] [Related]
7. Orally administration of cerium oxide nanozyme for computed tomography imaging and anti-inflammatory/anti-fibrotic therapy of inflammatory bowel disease.
Cao Y; Cheng K; Yang M; Deng Z; Ma Y; Yan X; Zhang Y; Jia Z; Wang J; Tu K; Liang J; Zhang M
J Nanobiotechnology; 2023 Jan; 21(1):21. PubMed ID: 36658555
[TBL] [Abstract][Full Text] [Related]
8. Orally administered titanium carbide nanosheets as anti-inflammatory therapy for colitis.
Hou L; Gong F; Liu B; Yang X; Chen L; Li G; Gong Y; Liang C; Yang N; Shen X; Liu Z; Cheng L
Theranostics; 2022; 12(8):3834-3846. PubMed ID: 35664066
[No Abstract] [Full Text] [Related]
9. Mo
Guo H; Guo H; Xie Y; Chen Y; Lu C; Yang Z; Zhu Y; Ouyang Y; Zhang Y; Wang X
Redox Biol; 2022 Oct; 56():102441. PubMed ID: 35985164
[TBL] [Abstract][Full Text] [Related]
10. Scale-Up Preparation of Manganese-Iron Prussian Blue Nanozymes as Potent Oral Nanomedicines for Acute Ulcerative Colitis.
Hu C; Yuan X; Zhao R; Hong B; Chen C; Zhu Q; Zheng Y; Hu J; Yuan Y; Wu Z; Zhang J; Tang C
Adv Healthc Mater; 2024 Jun; 13(16):e2400083. PubMed ID: 38447228
[TBL] [Abstract][Full Text] [Related]
11. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
[TBL] [Abstract][Full Text] [Related]
12. Oral Metal-Free Melanin Nanozymes for Natural and Durable Targeted Treatment of Inflammatory Bowel Disease (IBD).
Huang Q; Yang Y; Zhu Y; Chen Q; Zhao T; Xiao Z; Wang M; Song X; Jiang Y; Yang Y; Zhang J; Xiao Y; Nan Y; Wu W; Ai K
Small; 2023 May; 19(19):e2207350. PubMed ID: 36760016
[TBL] [Abstract][Full Text] [Related]
13. Construction of pH-Dependent Nanozymes with Oxygen Vacancies as the High-Efficient Reactive Oxygen Species Scavenger for Oral-Administrated Anti-Inflammatory Therapy.
Zhao N; Yang FE; Zhao CY; Lv SW; Wang J; Liu JM; Wang S
Adv Healthc Mater; 2021 Dec; 10(23):e2101618. PubMed ID: 34569192
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional two-dimensional Bi
Zhang C; Li Q; Shan J; Xing J; Liu X; Ma Y; Qian H; Chen X; Wang X; Wu LM; Yu Y
Acta Biomater; 2023 Apr; 160():252-264. PubMed ID: 36805534
[TBL] [Abstract][Full Text] [Related]
15. Orally Administered Silicon Hydrogen Nanomaterials as Target Therapy to Treat Intestinal Diseases.
Wei K; Gong F; Wu J; Tang W; Liao F; Han Z; Pei Z; Lei H; Wang L; Shao M; Liu Z; Cheng L
ACS Nano; 2023 Nov; 17(21):21539-21552. PubMed ID: 37843009
[TBL] [Abstract][Full Text] [Related]
16. An oral polyphenol host-guest nanoparticle for targeted therapy of inflammatory bowel disease.
Zhang C; Zeng F; Fan Z; He Z; Tai L; Peng Q; Zhang Y; Chao Z; Jiang W; Jia L; Han L
Acta Biomater; 2023 Oct; 169():422-433. PubMed ID: 37597682
[TBL] [Abstract][Full Text] [Related]
17. Orally Administrated Inflamed Colon-Targeted Nanotherapeutics for Inflammatory Bowel Disease Treatment by Oxidative Stress Level Modulation in Colitis.
Min DK; Kim YE; Kim MK; Choi SW; Park N; Kim J
ACS Nano; 2023 Dec; 17(23):24404-24416. PubMed ID: 38039189
[TBL] [Abstract][Full Text] [Related]
18. Tannic acid and zinc ion coordination of nanase for the treatment of inflammatory bowel disease by promoting mucosal repair and removing reactive oxygen and nitrogen species.
Zhang C; Li Q; Xing J; Yang Y; Zhu M; Lin L; Yu Y; Cai X; Wang X
Acta Biomater; 2024 Mar; 177():347-360. PubMed ID: 38373525
[TBL] [Abstract][Full Text] [Related]
19. Colon-targeted oral nanoparticles based on ROS-scavenging hydroxyethyl starch-curcumin conjugates for efficient inflammatory bowel disease therapy.
Xu C; Chen S; Chen C; Ming Y; Du J; Mu J; Luo F; Huang D; Wang N; Lin Z; Weng Z
Int J Pharm; 2022 Jul; 623():121884. PubMed ID: 35661797
[TBL] [Abstract][Full Text] [Related]
20. Biomimetic MOF Nanoparticles Delivery of C-Dot Nanozyme and CRISPR/Cas9 System for Site-Specific Treatment of Ulcerative Colitis.
Ma Y; Gao W; Zhang Y; Yang M; Yan X; Zhang Y; Li G; Liu C; Xu C; Zhang M
ACS Appl Mater Interfaces; 2022 Feb; 14(5):6358-6369. PubMed ID: 35099925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
